CTT Pharmaceutical Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0088
- Today's High:
- $0.0088
- Open Price:
- $0.0088
- 52W Low:
- $0.0085
- 52W High:
- $0.0697
- Prev. Close:
- $0.0088
- Volume:
- 600
Company Statistics
- Market Cap.:
- $18.97 million
- Book Value:
- 0.035
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- -153.57%
- Return on Equity TTM:
- -448.83%
Company Profile
CTT Pharmaceutical Holdings Inc had its IPO on under the ticker symbol CTTH.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. CTT Pharmaceutical Holdings Inc has a staff strength of 0 employees.
Stock update
Shares of CTT Pharmaceutical Holdings Inc opened at $0.01 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.01 - $0.01, and closed at $0.01.
This is a 0% increase from the previous day's closing price.
A total volume of 600 shares were traded at the close of the day’s session.
In the last one week, shares of CTT Pharmaceutical Holdings Inc have increased by +1.15%.
CTT Pharmaceutical Holdings Inc's Key Ratios
CTT Pharmaceutical Holdings Inc has a market cap of $18.97 million, indicating a price to book ratio of 10.6413 and a price to sales ratio of 0.
In the last 12-months CTT Pharmaceutical Holdings Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures CTT Pharmaceutical Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, CTT Pharmaceutical Holdings Inc’s operating margin was 0% while its return on assets stood at -153.57% with a return of equity of -448.83%.
In Q1, CTT Pharmaceutical Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
CTT Pharmaceutical Holdings Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CTT Pharmaceutical Holdings Inc’s profitability.
CTT Pharmaceutical Holdings Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -17.8707. Its price to sales ratio in the trailing 12-months stood at 0.
CTT Pharmaceutical Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $155701.00
- Total Liabilities
- $282609.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
CTT Pharmaceutical Holdings Inc ended 2024 with $155701.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $155701.00 while shareholder equity stood at $-126908.00.
CTT Pharmaceutical Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $282609.00 in other current liabilities, 208493.00 in common stock, $-4202856.00 in retained earnings and $0 in goodwill. Its cash balance stood at $105701.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
CTT Pharmaceutical Holdings Inc’s total current assets stands at $155701.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $50000.00 compared to accounts payable of $282609.00 and inventory worth $0.
In 2024, CTT Pharmaceutical Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, CTT Pharmaceutical Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.01
- 52-Week High
- $0.0697
- 52-Week Low
- $0.0085
- Analyst Target Price
- $
CTT Pharmaceutical Holdings Inc stock is currently trading at $0.01 per share. It touched a 52-week high of $0.0697 and a 52-week low of $0.0697. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.01 and 200-day moving average was $0.02 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About CTT Pharmaceutical Holdings Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.